Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.
about
The immune pathogenesis of scleroderma: context is everythingNIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group ReportA unifying hypothesis for scleroderma: identifying a target cell for scleroderma.Egr-ly awaiting a "personalized medicine" approach to treat scleroderma.Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity.Emerging targets for the treatment of scleroderma.Systemic sclerosis-dermatological aspects. Part 1: Pathogenesis, epidemiology, clinical findings.Is spleen circulation impaired in systemic sclerosis and what is the role of liver fibrosis?Adipose-derived stem cells accelerate neovascularization in ischaemic diabetic skin flap via expression of hypoxia-inducible factor-1α.Skin CD30(+) T cells and circulating levels of soluble CD30 are increased in patients with graft versus host diseaseHistopathological cutaneous alterations in systemic sclerosis: a clinicopathological studyA Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation.Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease.Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics.Genetic risk factors for sclerotic graft-versus-host disease.Nailfold capillary abnormalities in sclerodermatous chronic GVHD.Clinical significance of anti-endothelial cell antibody in allogeneic hematopoietic stem cell transplantation recipients with graft-versus-host disease.Myeloid cell populations and fibrogenic parameters in bleomycin- and HOCl-induced fibrosis.
P2860
Q24633658-8EF3A424-128B-4F9F-910C-2D03E81FEDD3Q28081289-54FFEBDF-3F7D-4F59-98A8-55FD0116C567Q33889221-7AF4E855-2043-4296-8D88-9C94166CC6BAQ34164828-C6AA8A5A-DF3B-4E61-882A-E2D1C9B19436Q34195672-0DCC6014-A209-45EA-B5D3-EB6886F90057Q34270856-B2AA9E0F-FCFD-486F-8938-E8A81D519601Q34295337-FF51DA57-6CEB-480C-B801-FEB5B9800583Q34757469-444AEF09-7AD8-40FF-9926-C8237BABDD91Q35216306-C66CD2E9-C116-466D-8181-AD81B3904335Q35309009-8E24C9FA-0C66-4359-86D4-4400E932AB2BQ35620376-43271A4C-09DF-4DB4-B68E-43D0FEEEAF26Q36471247-EEEC8566-542F-4F41-B230-5D091FEDF16FQ36945976-CBA9C2E9-2670-46AD-8B39-5EEF6C37B1E2Q39945922-B86FD679-D32C-409A-87DE-929A7B1FACA0Q41108286-7DB4781C-E9D7-440C-9C70-D5E02FDB223AQ43503769-CA31F9B8-5347-4482-BFCA-0A9812F2599CQ44322030-99210AAD-E832-42D0-97B9-839D761336BEQ50225552-B9556E5D-6A2A-4FE6-BE18-F4736309E4B3
P2860
Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cutaneous chronic graft-versus ...... eristic of systemic sclerosis.
@ast
Cutaneous chronic graft-versus ...... eristic of systemic sclerosis.
@en
type
label
Cutaneous chronic graft-versus ...... eristic of systemic sclerosis.
@ast
Cutaneous chronic graft-versus ...... eristic of systemic sclerosis.
@en
prefLabel
Cutaneous chronic graft-versus ...... eristic of systemic sclerosis.
@ast
Cutaneous chronic graft-versus ...... eristic of systemic sclerosis.
@en
P2093
P2860
P1433
P1476
Cutaneous chronic graft-versus ...... eristic of systemic sclerosis.
@en
P2093
Allen Gown
Howard M Shulman
Jo Nadine Fleming
Pamela Y Johnson
Richard A Nash
Stephen M Schwartz
Thomas N Wight
P2860
P356
10.1371/JOURNAL.PONE.0006203
P407
P577
2009-07-09T00:00:00Z